We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Consumer Unit Gets 483 for Internal Audit Shortfalls
GSK Consumer Unit Gets 483 for Internal Audit Shortfalls
April 2, 2012
GlaxoSmithKline Consumer Healthcare has received an FDA Form 483 for not conducting internal audits at its Saint Louis, Mo., plant as often as required by company protocol.